Christopher Peetz insider trades

Open-market stock purchases and sales by Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc, from SEC Form 4 filings since May 6, 2015.

Recent trades

DateStockTradeValue
Oct 6, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Oct 6, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Sep 1, 2026MIRM Mirum Pharmaceuticals, IncSold$2.1M
Sep 1, 2026MIRM Mirum Pharmaceuticals, IncSold$815K
Sep 1, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Aug 10, 2026MIRM Mirum Pharmaceuticals, IncSold$1.2M
Aug 10, 2026MIRM Mirum Pharmaceuticals, IncSold$597K
Aug 10, 2026MIRM Mirum Pharmaceuticals, IncSold$230K
Aug 10, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Jul 15, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Jul 15, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Jul 15, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Jul 6, 2026MIRM Mirum Pharmaceuticals, IncSold$1.5M
Jul 6, 2026MIRM Mirum Pharmaceuticals, IncSold$512K
Jul 6, 2026MIRM Mirum Pharmaceuticals, IncSold$244K
Jul 6, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Jul 6, 2026MIRM Mirum Pharmaceuticals, IncSold$213K
Jun 1, 2026MIRM Mirum Pharmaceuticals, IncSold$246K
Jun 1, 2026MIRM Mirum Pharmaceuticals, IncSold$666K
Jun 1, 2026MIRM Mirum Pharmaceuticals, IncSold$192K
Jun 1, 2026MIRM Mirum Pharmaceuticals, IncSold$1.6M
Jun 1, 2026MIRM Mirum Pharmaceuticals, IncSold$100K
Jun 1, 2026MIRM Mirum Pharmaceuticals, IncSold$88K
Jun 1, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Mar 16, 2026MIRM Mirum Pharmaceuticals, IncSold$3.8M

Companies traded

  • MIRM Mirum Pharmaceuticals, Inc: 6 buys, 32 sales, last Oct 6, 2026
  • ARQT Arcutis Biotherapeutics, Inc: other filings, last Jul 15, 2026
  • ALPN Alpine Immune Sciences, Inc: 1 buy, 1 sale, last May 20, 2024
  • TBRA Tobira Therapeutics, Inc: other filings, last Nov 1, 2016

Get free alerts when Christopher Peetz files a new trade →